Ad.mda-7 (IL-24) selectively induces apoptosis in hepatocellular carcinoma cell lines, suppresses metastasis, and enhances the effect of doxorubicin on xenograft tumors

Oncology Research

Volumn 18, Issue 11-12, 2010, Pages 561-574

  Wang, Cong Jun ^a   Zhang, Hui ^a   Chen, Kun ^b   Zheng, Jian Wei ^b   Xiao, Chao Wen ^b   Ji, Wen Wei ^b   Yu, Yuan ^b   Hu, Hui Yi ^b   Li, Yan ^c   Xue, Xin Bo ^b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

Antiangiogenesis; Apoptosis; Doxorubicin (ADM); Gene therapy; Growth arrest; Hepatocellular carcinoma (HCC); MDA 7 IL 24; Metastasis; Signal transducer and activator of transcription 3 (STAT3)

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; CADHERIN; DOXORUBICIN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-24; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN;

ADENOVIRIDAE; ANIMAL; APOPTOSIS; CELL CYCLE; DRUG SCREENING; GENE THERAPY; GENETICS; HUMAN; LIVER NEOPLASMS, EXPERIMENTAL; METABOLISM; METASTASIS; MOUSE; PATHOLOGY; TUMOR CELL LINE;

ADENOVIRIDAE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CADHERINS; CELL CYCLE; CELL LINE, TUMOR; DOXORUBICIN; GENETIC THERAPY; HUMANS; INTERLEUKINS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM METASTASIS; STAT3 TRANSCRIPTION FACTOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77956896379     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504010X12767359113929     Document Type: Article

References (47)

1. Tanaka, K.; Shimada, H.; Matsuo, K.; Nagano, Y.; Endo, I.; Togo, S. Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 141:589-597; 2007.
2. Shimizu, M.; Takai, K.; Moriwaki, H. Strategy and mechanism for the prevention of hepatocellular carcinoma: Phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention. Cancer Sci. 100:369-374; 2009.
3. Tanaka, S.; Arii, S. Molecularly targeted therapy for hepatocellular carcinoma. Cancer Sci. 100:1-8; 2009.
4. Liu, F.; Wang, P.; Jiang, X.; Tan, G.; Qiao, H.; Jiang, H.; Krissansen, G. W.; Sun, X. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma. Cancer Sci. 99:2055-2061; 2008.
5. Pestka, S.; Krause, C.D.; Sarkar, D.; Walter, M. R.; Shi, Y.; Fisher, P. B. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22:929-979; 2004.
6. Fisher, P. B.; Sarkar, D.; Lebedeva, I. V.; Emdad, L.; Gupta, P.; Sauane, M.; Su, Z. Z.; Grant, S.; Dent, P.; Curiel, D. T.; Senzer, N.; Nemunaitis, J. Melanoma differentiation associated gene-7/interleukin-24 (MDA-7/IL-24): Novel gene therapeutic for metastatic melanoma. Toxicol. Appl. Pharmacol. 111:596-628; 2006.
7. Jiang, H.; Lin, J. J.; Su, Z. Z.; Goldstein, N. I.; Fisher, P. B. Subtraction hybridization identifies a novel melanoma differentiation associated gene, MDA-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11:2477-2486; 1995.
8. Shanker, M.; Gopalan, B.; Patel, S.; Bocangel, D.; Chada, S.; Ramesh, R. Vitamin E succinate in combination with MDA-7 results in enhanced human ovarian tumor cell killing through modulation of extrinsic and intrinsic apoptotic pathways. Cancer Lett. 254:217-226; 2007.
9. Gopalan, B.; Shanker, M.; Chada, S.; Ramesh, R. MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo. Mol. Cancer 6:11; 2007.
10. Sainz-Perez, A.; Gary-Gouy, H.; Portier, A.; Davi, F.; Merle-Beral, H.; Galanaud, P.; Dalloul, A. High MDA-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia. Leukemia 20:498-l504; 2006.
11. Su, Z. Z.; Lebedeva, I. V.; Sarkar, D.; Gopalkrishnan, R. V.; Sauane, M.; Sigmon, C.; Yacoub, A.; Valerie, K.; Dent, P.; Fisher, P. B. Melanoma differentiation associated gene-7, MDA-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53 independent manner. Oncogene 22: 1164-1180; 2003.
12. Inoue, S.; Hartman, A.; Branch, C. D.; Bucana, C. D.; Bekele, B. N.; Stephens, L. C.; Chada, S.; Ramesh, R. MDA-7 In combination with bevacizumab treatment produces a synergistic and complete inhibitory effect on lung tumor xenograft. Mol. Ther. 15:287-294; 2007.
13. Emdad, L.; Lebedeva, I. V.; Su, Z. Z.; Gupta, P.; Sarkar, D.; Settleman, J.; Fisher, P. B. Combinatorial treatment of non-small-cell lung cancers with gefitinib and Ad.mda-7 enhances apoptosis-induction and reverses resistance to a single therapy. J. Cell Physiol. 210:549-559; 2007.
14. Pataer, A.; Bocangel, D.; Chada, S.; Roth, J. A.; Hunt, K. K.; Swisher, S. G. Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue. Cancer Gene Ther. 14:12-18; 2007.
15. Bocangel, D.; Zheng, M.; Mhashilkar, A.; Liu, Y.; Ramesh, R.; Hunt, K. K.; Chada, S. Combinatorial synergy induced by adenoviral-mediated mda-7 and herceptin in Her-2+ breast cancer cells. Cancer Gene Ther. 13:958-968; 2006. (Pubitemid 44373796)
16. Lebedeva, I. V.; Su, Z. Z.; Emdad, L.; Kolomeyer, A.; Sarkar, D.; Kitada, S.; Waxman, S.; Reed, J. C.; Fisher, P. B. Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant Kras colorectal cancer cells. Oncogene 26:733-744; 2007.
17. Zhao, L.; Dong, A.; Gu, J.; Liu, Z.; Zhang, Y.; Zhang, W.; Wang, Y.; He, L.; Qian, C.; Qian, Q.; Liu, X. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer. Cancer Gene Ther. 13:1011-1022; 2006. (Pubitemid 44564737)
18. Lebedeva, I. V.; Washington, I.; Sarkar, D.; Clark, J. A.; Fine, R. L.; Dent, P.; Curiel, D. T.; Turro, N. J.; Fisher, P. B. Strategy for reversing resistance to a single anticancer agent in human prostate and pancreatic carcinomas. Proc. Natl. Acad. Sci. USA 104:3484-3489; 2007.
19. Su, Z. Z.; Lebedeva, I. V.; Sarkar, D.; Emdad, L.; Gupta, P.; Kitada, S.; Dent, P.; Reed, J. C.; Fisher, P. B. Ionizing radiation enhances therapeutic activity of MDA-7/IL-24: Overcoming radiation- and MDA-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2. Oncogene 25:2339-2348; 2006.
20. Lebedeva, I. V.; Sarkar, D.; Su, Z. Z.; Gopalkrishnan, R. V.; Athar, M.; Randolph, A.; Valerie, K.; Dent, P.; Fisher, P. B. Molecular target-based therapy of pancreatic cancer. Cancer Res. 66:2403-2413; 2006.
21. Sarkar, D.; Lebedeva, I. V.; Gupta, P.; Emdad, L.; Sauane, M.; Dent, P.; Curiel, D. T.; Fisher, P. B. Melanoma differentiation associated gene-7 (MDA-7)/IL-24: a 'magic bullet' for cancer therapy? Expert Opin. Biol. Ther. 7:577-586; 2007.
22. Inoue, S.; Shanker, M.; Miyahara, R.; Gopalan, B.; Patel, S.; Oida, Y.; Branch, C. D.; Munshi, A.; Meyn, R. E.; Andreeff, M.; Tanaka, F.; Mhashilkar, A. M.; Chada, S.; Ramesh, R. MDA-7/IL-24-based cancer gene therapy: Translation from the laboratory to the clinic. Curr. Gene Ther. 6:73-91; 2006.
23. Gupta, P.; Su, Z. Z.; Lebedeva, I. V.; Sarkar, D.; Sauane, M.; Emdad, L.; Bachelor, M. A.; Grant, S.; Curiel, D. T.; Dent, P.; Fisher, P. B. mda-7/IL-24: Multifunctional cancer-specific apoptosis-inducing cytokine. Pharmacol. Ther. 111:596-628; 2006.
24. Wang, C. J.; Xue, X. B.; Yi, J. L.; Chen, K.; Zheng, J. W.; Wang, J.; Zeng, J. P.; Xu, R. H. Melanoma differentiation-associated gene-7, MDA-7/IL-24, selectively induces growth suppression, apoptosis in human hepatocellular carcinoma cell line HepG2 by replication-incompetent adenovirus vector. World J. Gastroenterol. 12:1774-1779; 2006.
25. Li, Y.; Tang, Z. Y.; Tian, B.; Ye, S. L.; Qin, L. X.; Xue, Q.; Sun, R. X. Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: Study in nude mice model and clinical patients. J. Cancer Res. Clin. Oncol. 132:515-520; 2006.
26. Qin, L. X.; Tang, Z. Y. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: A review of the literature. J. Cancer Res. Clin. Oncol. 130:497-513; 2004.
27. Sun, B.; Zhang, S.; Zhang, D.; Gu, Y.; Zhang, W.; Zhao, X. The influence of different microenvironments on melanoma invasiveness and microcirculation patterns: An animal experiment study in the mouse model. J. Cancer Res. Clin. Oncol. 133:979-985; 2007.
28. Glasgow, E.; Mishra, L. Transforming growth factor-beta signaling and ubiquitinators in cancer. Endocr. Relat. Cancer 15:59-72; 2008.
29. Kerbel, R. S. Tumor angiogenesis. N. Engl. J. Med. 358: 2039-2049; 2008.
30. Zimmers, T. A.; Jin, X. L.; Gutierrez, J. C.; Acosta, C.; McKillop, I. H.; Pierce, R. H.; Koniaris, L. G. Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis. J. Cancer Res. Clin. Oncol. 134:753-759; 2008.
31. Tong, A. W.; Nemunaitis, J.; Su, D.; Zhang, Y.; Cunningham, C.; Senzer, N.; Netto, G.; Rich, D.; Mhashilkar, A.; Parker, K.; Coffee, K.; Ramesh, R.; Ekmekcioglu, S.; Grimm, E. A.; van Wart Hood, J.; Merritt, J.; Chada, S. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (MDA-7/IL24): Biologic outcome in advanced cancer patients. Mol. Ther. 11:160-172; 2005.
32. Cunningham, C. C.; Chada, S.; Merritt, J. A.; Tong, A.; Senzer, N.; Zhang, Y.; Mhashilkar, A.; Parker, K.; Vukelja, S.; Richards, D.; Hood, J.; Coffee, K.; Nemunaitis, J. Clinical and local biological effects of an intratumoral injection of MDA-7 (IL24; INGN 241) in patients with advanced carcinoma: A phase I study. Mol. Ther. 11: 149-159; 2005.
33. Ding, S. J.; Li, Y.; Shao, X. X.; Zhou, H.; Zeng, R.; Tang, Z. Y.; Xia, Q. C. Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials. Proteomics 4:982-994; 2004.
34. Ledoux, S.; Yang, R.; Friedlander, G.; Laouari, D. Glucose depletion enhances P-glycoprotein expression in hepatoma cells: Role of endoplasmic reticulum stress response. Cancer Res. 63:7284-7290; 2003. (Pubitemid 37413469)
35. Yacoub, A.; Hamed, H.; Emdad, L.; Dos Santos, W.; Gupta, P.; Broaddus, W. C.; Ramakrishnan, V.; Sarkar, D.; Shah, K.; Curiel, D. T.; Grant, S.; Fisher, P. B.; Dent, P. MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors. Cancer Biol. Ther. 7:917-933; 2008.
36. Sauane, M.; Gupta, P.; Lebedeva, I. V.; Su, Z. Z.; Sarkar, D.; Randolph, A.; Valerie, K.; Gopalkrishnan, R. V.; Fisher, P. B. N-glycosylation of MDA-7/IL-24 is dispensable for tumor cell-specific apoptosis and "bystander" antitumor activity. Cancer Res. 66:11869-11877; 2006.
37. Tian, B.; Li, Y.; Ji, X. N.; Chen, J.; Xue, Q.; Ye, S. L.; Liu, Y. K.; Tang, Z. Y. Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential. J. Cancer Res. Clin. Oncol. 31:80-86; 2005.
38. Wu, X.; Jia, H. L.; Wang, Y. F.; Ren, N.; Ye, Q. H.; Sun, H. C.; Wang, L.; Liu, Y. K.; Tang, Z. Y.; Qin, L. X. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma. Oncogene 25:1832-1840; 2006.
39. Li, Y.; Tian, B.; Yang, J.; Zhao, L.; Wu, X.; Ye, S. L.; Liu, Y. K.; Tang, Z. Y. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. J. Cancer Res. Clin. Oncol. 130:460-468; 2004.
40. Bartoli, M.; Platt, D.; Lemtalsi, T.; Gu, X.; Brooks, S. E.; Marrero, M. B.; Caldwell, R. B. VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J. 17:1562-1564; 2003.
41. Yahata, Y.; Shirakata, Y.; Tokumaru, S.; Yamasaki, K.; Sayama, K.; Hanakawa, Y.; Detmar, M.; Hashimoto, K. Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation. J. Biol. Chem. 278:40026-40031; 2003.
42. Lin, L.; Amin, R.; Gallicano, G. I.; Glasgow, E.; Jogunoori, W.; Jessup, J. M.; Zasloff, M.; Marshall, J. L.; Shetty, K.; Johnson, L.; Mishra, L.; He, A. R. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Oncogene 28:961-972; 2009.
43. Berasain, C.; Castillo, J.; Perugorria, M. J.; Latasa, M. U.; Prieto, J.; Avila, M. A. Inflammation and liver cancer: New molecular links. Ann. NY Acad. Sci. 1155:206-221; 2009.
44. Xu, Q.; Briggs, J.; Park, S.; Niu, G.; Kortylewski, M.; Zhang, S.; Gritsko, T.; Turkson, J.; Kay, H.; Semenza, G. L.; Cheng, J. Q.; Jove, R.; Yu, H. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 24: 5552-5560; 2005.
45. Li, W. C.; Ye, S. L.; Sun, R. X.; Liu, Y. K.; Tang, Z. Y.; Kim, Y.; Karras, J. G.; Zhang, H. Inhibition of growth and metastasis of human hepatocellular carcinoma by anti-sense oligonucleotide targeting signal transducer and activator of transcription 3. Clin. Cancer Res. 12:7140-7148; 2006.
46. Ogata, H.; Chinen, T.; Yoshida, T.; Kinjyo, I.; Takaesu, G.; Shiraishi, H.; Iida, M.; Kobayashi, T.; Yoshimura, A. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene 25:2520-2530; 2006.
47. Ramesh, R.; Mhashilkar, A. M.; Tanaka, F.; Saito, Y.; Branch, C. D.; Sieger, K.; Mumm, J. B.; Stewart, A. L.; Boquoi, A.; Dumoutier, L.; Grimm, E. A.; Renauld, J. C.; Kotenko, S.; Chada, S. Melanoma differentiation associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res. 63: 5105-5113; 2003.